- Investing Ideas
- /
- Materials Healthcare Sector
Materials Healthcare Sector
Results
2309
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
2,309 companies
Sienna Senior Living
Market Cap: CA$1.6b
Provides senior living services in Canada.
SIA
CA$17.93
7D
1.9%
1Y
20.0%
Innoviva
Market Cap: US$1.2b
Engages in the development and commercialization of pharmaceutical products in the United States and internationally.
INVA
US$18.58
7D
0.1%
1Y
16.3%
Amphastar Pharmaceuticals
Market Cap: US$1.1b
A bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France.
AMPH
US$24.87
7D
3.1%
1Y
-42.8%
Ocular Therapeutix
Market Cap: US$1.1b
A biopharmaceutical company, engages in the development and commercialization of therapies for retinal diseases and other eye conditions using its bioresorbable hydrogel-based formulation technology in the United States.
OCUL
US$7.22
7D
2.3%
1Y
17.0%
Dynavax Technologies
Market Cap: US$1.1b
A commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States and internationally.
DVAX
US$9.67
7D
2.8%
1Y
-13.0%
10x Genomics
Market Cap: US$1.1b
A life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the Americas, Europe, the Middle East, Africa, China, and the Asia Pacific.
TXG
US$9.39
7D
7.1%
1Y
-62.5%
Natus Medical
Market Cap: US$1.1b
Natus Medical Incorporated provides medical device solutions focuses on the diagnosis and treatment of patients with central nervous and sensory system disorders worldwide.
NTUS
US$32.96
7D
0.8%
1Y
34.4%
89bio
Market Cap: US$1.1b
A clinical-stage biopharmaceutical company, engages in the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases.
ETNB
US$7.78
7D
1.0%
1Y
-9.9%
Pulse Biosciences
Market Cap: US$1.1b
Operates as a novel bioelectric medicine company.
PLSE
US$17.19
7D
0.7%
1Y
120.1%
Aurinia Pharmaceuticals
Market Cap: US$1.1b
A biopharmaceutical company that engages in delivering therapies to people living with autoimmune diseases with high unmet medical needs.
AUPH
US$8.19
7D
2.4%
1Y
42.2%
Spire Healthcare Group
Market Cap: UK£800.7m
Owns and operates private hospitals and clinics in the United Kingdom.
SPI
UK£1.99
7D
-2.2%
1Y
-23.0%
Establishment Labs Holdings
Market Cap: US$1.1b
A medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgeries.
ESTA
US$36.16
7D
6.6%
1Y
-36.1%
Neuren Pharmaceuticals
Market Cap: AU$1.6b
A biopharmaceutical company, develops drugs for the treatment of neurological disorders.
NEU
AU$13.19
7D
-0.8%
1Y
-37.5%
agilon health
Market Cap: US$1.1b
Provides healthcare services for seniors through primary care physicians in the communities of the United States.
AGL
US$2.45
7D
-15.2%
1Y
-54.7%
OPKO Health
Market Cap: US$1.1b
A healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally.
OPK
US$1.33
7D
7.3%
1Y
0.8%
MiMedx Group
Market Cap: US$1.0b
Develops and distributes placental tissue allografts for various sectors of healthcare.
MDXG
US$7.05
7D
0%
1Y
-9.6%
BioLife Solutions
Market Cap: US$1.0b
Develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally.
BLFS
US$23.59
7D
1.3%
1Y
7.4%
Viridian Therapeutics
Market Cap: US$1.0b
Engages in discovering, developing, and commercializing treatments for serious and rare diseases.
VRDN
US$12.94
7D
4.4%
1Y
-3.8%
Craneware
Market Cap: UK£773.9m
Develops, licenses, and supports computer software for the healthcare industry in the United States.
CRW
UK£22.10
7D
23.5%
1Y
3.3%
Evolent Health
Market Cap: US$1.0b
Through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States.
EVH
US$8.83
7D
-2.4%
1Y
-61.7%
Novavax
Market Cap: US$1.0b
A biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally.
NVAX
US$6.73
7D
12.6%
1Y
-48.3%
Pennant Group
Market Cap: US$1.0b
Provides healthcare services in the United States.
PNTG
US$30.22
7D
5.7%
1Y
31.3%
Integra LifeSciences Holdings
Market Cap: US$1.0b
Manufactures and sells surgical instrument, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology.
IART
US$13.57
7D
10.8%
1Y
-50.7%
NeoGenomics
Market Cap: US$1.0b
Operates a network of cancer-focused testing laboratories in the United States and the United Kingdom.
NEO
US$8.11
7D
0.7%
1Y
-45.2%
Mineralys Therapeutics
Market Cap: US$1.0b
A clinical-stage biopharmaceutical company, develops medicines to target diseases driven by dysregulated aldosterone in the United States.
MLYS
US$15.35
7D
4.8%
1Y
18.1%
InMode
Market Cap: US$998.3m
Designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States, Europe, Asia, and internationally.
INMD
US$14.67
7D
1.5%
1Y
-20.5%
Wave Life Sciences
Market Cap: US$978.8m
A clinical-stage biotechnology company, designs, develops, and commercializes ribonucleic acid (RNA) medicines through PRISM, a discovery and drug development platform.
WVE
US$6.30
7D
-3.7%
1Y
6.8%
Oculis Holding
Market Cap: US$968.9m
A clinical-stage biopharmaceutical company, develops drug candidates to treat ophthalmic diseases in Switzerland, Iceland, and internationally.
OCS
US$17.85
7D
-3.9%
1Y
49.1%
Phibro Animal Health
Market Cap: US$965.9m
Operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally.
PAHC
US$24.00
7D
6.8%
1Y
30.4%
Gyre Therapeutics
Market Cap: US$963.8m
A pharmaceutical company, engages in the development and commercialization of small-molecule, anti-inflammatory, and anti-fibrotic drugs targeting organ fibrosis.
GYRE
US$11.35
7D
19.1%
1Y
-20.3%
Nutex Health
Market Cap: US$960.6m
Operates as a physician-led, healthcare services, and operations company in the United States.
NUTX
US$174.71
7D
44.7%
1Y
2,353.8%
Collegium Pharmaceutical
Market Cap: US$943.1m
A specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management.
COLL
US$30.23
7D
4.6%
1Y
-6.9%
Harrow
Market Cap: US$940.2m
An eyecare pharmaceutical company, engages in the discovery, development, and commercialization of ophthalmic pharmaceutical products.
HROW
US$28.41
7D
16.4%
1Y
69.5%
Nanosonics
Market Cap: AU$1.5b
Operates as an infection prevention company globally.
NAN
AU$4.79
7D
-1.4%
1Y
69.9%
Arcus Biosciences
Market Cap: US$907.4m
A clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States.
RCUS
US$8.56
7D
3.4%
1Y
-49.3%
STAAR Surgical
Market Cap: US$905.5m
Designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye.
STAA
US$19.22
7D
-1.0%
1Y
-55.0%